July 20, 2023
HUGE NEWS! Historic Hemp And CBD Hearing Ahead
We’ve been working diligently behind the scenes over the past several weeks and are excited to finally share the big news.
On Thursday, July 27th at 2:00 PM ET, U.S. Hemp Roundtable General Counsel Jonathan Miller will be testifying during a historic hearing on hemp and CBD before the House Oversight and Accountability Committee’s Subcommittee on Health Care and Financial Services. The hearing, “Hemp in the Modern World: The Years long Wait for FDA Action,” will be the first time Congress will formally scrutinize the impact of the Food and Drug Administration’s failure to develop a regulatory pathway for the sale of ingestible hemp products such as CBD. Oversight Committee Chairman James Comer (R-KY) first indicated his intention to hold such a hearing in an exclusive interview with Mr. Miller in January.
“I am honored to serve as a witness for this historic hearing to testify to the extraordinary challenges faced by hemp farmers and CBD consumers over the past five years.” said Jonathan Miller, General Counsel of the U.S. Hemp Roundtable. “The U.S. Hemp Roundtable is grateful to Chairman James Comer, subcommittee chair Lisa McClain, and ranking member Katie Porter for this critical opportunity. I look forward to shedding light on the urgent need for clear regulations that ensure consumer safety and promote the growth of the hemp industry.”
Mr. Miller’s testimony will focus on the tremendous disruption to hemp farmers and businesses caused by the FDA’s inaction. Additional witnesses will include Rayetta G. Henderson, Ph.D., Senior Managing Scientist, ToxStrategies, LLC, and Rich Badaracco, former Drug Enforcement Administration agent, and current Board Member of the US Hemp Authority, the hemp industry’s self-regulating organization.
Check out our official press release here.